Sugammadex Piramal ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Dipentum 500 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

dipentum 500 mg

atnahs pharma netherlands b.v. - olsalazinnatrium - tablett - 500 mg

Sugammadex Mylan ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Baxter 100 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

sugammadex baxter 100 mg/ ml

baxter holding b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml